Scarica l'app Stockscreener
64.49
0.26%
0.17
Dopo l'orario di chiusura:
64.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$64.32
Aprire:
$64.2
Volume 24 ore:
2.17M
Relative Volume:
0.96
Capitalizzazione di mercato:
$14.64B
Reddito:
$4.03B
Utile/perdita netta:
$789.50M
Rapporto P/E:
19.37
EPS:
3.33
Flusso di cassa netto:
$1.15B
1 W Prestazione:
+1.98%
1M Prestazione:
-8.36%
6M Prestazione:
-19.41%
1 anno Prestazione:
-14.94%
Intervallo 1D:
$63.76
$64.70
Intervallo di 1 settimana:
$62.70
$65.18
Portata 52W:
$62.70
$84.67
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
64.49 | 14.64B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
591.79 | 211.07B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.43 | 65.30B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.31 | 44.67B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.69 | 34.04B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
88.48 | 17.62B | 3.90B | 392.30M | 288.10M | 1.95 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Do Options Traders Know Something About Hologic (HOLX) Stock We Don't? - Yahoo Finance
BioZorb Lawsuit - Lawsuit Information Center Blog
Digital X-ray Devices Market Witnessing High Demand | Key Trends - openPR
Fluoroscopy Devices Market Set to Expand | Innovations, - openPR
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2025: Key Trends, Major Players, Opportunities, Strategies, M&As, 2018-2023, 2028F, 2033F - GlobeNewswire Inc.
Global Stereotactic Breast Biopsy Market Overview, Future - openPR
Hologic Gains CE Mark for Affirm Contrast Biopsy Software - MPO-mag
Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software - Silicon Canals
Breast Cancer Diagnostic Market: Imaging Advancements, Growth - openPR
Molecular Diagnostics Market: Is Booming Worldwide 2024-2032 | Hologic, Abbott, MDxHealth - openPR
Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay - BioSpace
FDA OKs Hologic’s Aptima SARS-CoV-2 Assay - MPO-mag
Hologic's SWOT analysis: diagnostics firm faces growth challenges By Investing.com - Investing.com South Africa
Hologic's SWOT analysis: diagnostics firm faces growth challenges - Investing.com India
These 4 Big Cap Health Care Stocks Just Hit New 52-Week Lows - Forbes
Morcellator Market SWOT Analysis by Key Players- Karl Storz, Hologic, Medtronic - openPR
Cervical Cytology Brushes Market Booming Growth: Future - openPR
Why Hologic (HOLX) Outpaced the Stock Market Today - MSN
Entropy Technologies LP Trims Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 15,820 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Gynecological Devices Market Projected To Witness Substantial Growth, 2025-2032 | Ethicon, Inc., Hologic, Inc, - EIN News
Leerink Partnrs Has Positive Outlook of Hologic Q4 Earnings - MarketBeat
William Blair Has Pessimistic View of Hologic Q2 Earnings - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Receives $85.77 Consensus Price Target from Analysts - MarketBeat
Hologic (NASDAQ:HOLX) Hits New 1-Year LowWhat's Next? - MarketBeat
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes - MSN
Hologic Stock: Analyst Estimates & Ratings - Nasdaq
Here's Why You Should Retain HOLX Stock in Your Portfolio Now - Nasdaq
Global Access Initiative - Hologic
Biopsy Devices Market Booming Demand, Growth Opportunities, - openPR
Stephens Investment Management Group LLC Has $53.89 Million Stock Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - MSN
North America Diagnostic Imaging Market to Drive Growth with - openPR
Leerink Partnrs Has Pessimistic View of Hologic Q3 Earnings - MarketBeat
William Blair Estimates Hologic's Q3 Earnings (NASDAQ:HOLX) - MarketBeat
Hologic Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Deciphering Hologic (HOLX) International Revenue Trends - Nasdaq
Hologic (NASDAQ:HOLX) Price Target Cut to $85.00 by Analysts at Royal Bank of Canada - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by Lecap Asset Management Ltd. - MarketBeat
Evercore ISI Has Lowered Expectations for Hologic (NASDAQ:HOLX) Stock Price - MarketBeat
Hologic's (HOLX) Outperform Rating Reaffirmed at Raymond James - MarketBeat
Hologic shares fall 3% as Q2 guidance disappoints - MSN
HOLXHologic Inc Latest Stock News & Market Updates - StockTitan
Breast Health Performance Likely to Aid Hologic's Q1 Earnings - MSN
Hologic, Inc. (NASDAQ:HOLX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Canada Finance
abrdn plc Sells 13,484 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic is Now Oversold (HOLX) - Nasdaq
Hologic, Inc. (NASDAQ:HOLX) Just Reported, And Analysts Assigned A US$80.53 Price Target - Simply Wall St
Hologic outlines Q2 revenue guidance of $995M–$1.005B amid expected diagnostics growth - MSN
The Shocking Fall of Hologic: What Investors Need to Know! - Jomfruland.net
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.85%
3.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):